Document is current

Any future updates will be listed below

Correction to: Comparison of the Efficacy and Safety of Bilastine 20 mg versus Fexofenadine 180 mg for Treatment of Perennial Allergic Rhinitis: Randomized Controlled Study

Crossref DOI link: https://doi.org/10.1007/s12070-024-05010-1

Published Online: 2024-08-24

Published Print: 2024-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark